Medicare Enrolled
Dr. David Fischler, MD
Internal Medicine · East Brunswick, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fischler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fischler?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fischler
Dr. David Fischler is an internal medicine specialist in East Brunswick, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fischler performed 2,571 Medicare services across 1,382 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fischler received a total of $5,455 from 36 pharmaceutical and/or device companies across 353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fischler is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in NJ
$5,455 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,571
Medicare services
Top 16% in NJ for internal medicine
1,382
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~135 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
656 | $102 | $435 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
615 | $102 | $466 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
341 | $68 | $316 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
233 | $70 | $315 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
125 | $185 | $1,217 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
84 | $138 | $681 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
61 | $112 | $561 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
60 | $24 | $138 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
60 | $49 | $238 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
60 | $52 | $248 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $46 | $167 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
42 | $34 | $91 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
40 | $72 | $170 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
37 | $101 | $450 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
32 | $50 | $152 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
29 | $152 | $861 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $70 | $480 |
| New patient office visit, complex (60-74 min) | 13 | $183 | $780 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
12 | $35 | $262 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,455
Total received (2018-2024)
Avg $779/year across 7 years
Top 15% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
353
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,284 (96.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$150 (2.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,204
2023
$899
2022
$681
2021
$445
2020
$189
2019
$1,060
2018
$977
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$370
Grifols USA, LLC
$121
Mylan Specialty L.P.
$109
GENZYME CORPORATION
$106
GlaxoSmithKline, LLC.
$99
CSL Behring
$82
Regeneron Healthcare Solutions, Inc.
$77
Boehringer Ingelheim Pharmaceuticals, Inc.
$65
Merck Sharp & Dohme LLC
$34
PFIZER INC.
$32
Bayer Healthcare Pharmaceuticals Inc.
$30
Baxter Healthcare
$21
Insmed, Inc.
$18
Genentech USA, Inc.
$15
Amgen Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$13
Top 3 companies account for 49.8% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,003
AstraZeneca Pharmaceuticals LP
$939
Boehringer Ingelheim Pharmaceuticals, Inc.
$503
Mylan Specialty L.P.
$440
GENZYME CORPORATION
$344
CSL Behring
$304
Grifols USA, LLC
$177
Regeneron Healthcare Solutions, Inc.
$160
Insmed, Inc.
$156
COMSORT, Inc
$150
Genentech USA, Inc.
$137
Sunovion Pharmaceuticals Inc.
$127
Takeda Pharmaceuticals U.S.A., Inc.
$112
Electromed, Inc.
$101
PFIZER INC.
$100
E.R. Squibb & Sons, L.L.C.
$78
Shire North American Group Inc
$77
Philips Electronics North America Corporation
$74
Amgen Inc.
$62
Harmony Biosciences LLC
$50
Merck Sharp & Dohme LLC
$50
Bayer HealthCare Pharmaceuticals Inc.
$37
Axsome Therapeutics, Inc.
$35
Bayer Healthcare Pharmaceuticals Inc.
$30
Novartis Pharmaceuticals Corporation
$28
Janssen Pharmaceuticals, Inc
$23
Baxter Healthcare
$21
United Therapeutics Corporation
$21
Inogen, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$15
Actelion Pharmaceuticals US, Inc.
$15
Mallinckrodt Hospital Products Inc.
$14
Mallinckrodt Enterprises LLC
$13
HARMONY BIOSCIENCES LLC
$13
Mitsubishi Tanabe Pharma America, Inc.
$12
Top 3 companies account for 44.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BROVANA · CHANTIX · CUVITRU · DIFICID · DUPIXENT · Dymista · ELIQUIS · Esbriet · FASENRA · GLASSIA · Hillrom - Vest System Model 105 Home Care · Hizentra · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · LONHALA MAGNAIR · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT MACITENTAN · PREVNAR - 13 · Prolastin-C Liquid · Radicava · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Trilogy 100 · UTIBRON · UTIBRON NEOHALER · Utibron · WAKIX · Wakix · XARELTO · XOLAIR · Xembify · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
2,714
Per 100K population
315.0
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fischler is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NJ), with low-engagement industry engagement in the top 15% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fischler experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Fischler performed 656 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fischler receive payments from pharmaceutical companies?
Yes. Dr. Fischler received a total of $5,455 from 36 companies across 353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fischler's costs compare to other internal medicine physicians in East Brunswick?
Dr. Fischler's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fischler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in East Brunswick
Browse internal medicine physicians in East Brunswick ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology